Samsung Electronics Co., a global leader in memory chip manufacturing, plans to boost the memory density of its DRAM and NAND flash chips to unprecedented levels. The move aims to enhance their storage capacity and processing speed to cater to the high demands of hyperscale artificial intelligence (AI). Samsung is developing an 11-nanometer DRAM, which is expected to set a new industry standard for memory density. The company is also working on the highest layer of the 9th-generation V-NAND that can be implemented in a double-stack structure.
In the medical field, there is growing investment in AI technology. Pharmaceutical titan Johnson & Johnson has shown interest in South Korean bio startups known for their innovative prowess. Johnson & Johnson continues to support startups in Asia through their global startup program, JLabs.
The View Conference, a forum for discussing the impacts of innovative technologies on the creative industries, has placed a significant emphasis on animation and AI, with a focus on exploring the future of storytelling. The event aims to host both skeptics and proponents of AI, fostering a balanced discourse on the role and appropriate use of AI within the industry.
The ongoing advancements in AI technology are profoundly influencing both the tech and medical fields. Samsung's enhancements to their AI-compatible memory chips and Johnson & Johnson's growing interest in bio startups leveraging AI show that the pace of advancements is set to accelerate. Meanwhile, the role of AI in sectors like the entertainment industry continues to be scrutinized, pushing the boundaries of how the technology can be creatively used for storytelling.
Shifting focus to networking technology, Juniper Networks, a provider of a wide range of networking products, is set to report its Q3 earnings soon. The company's AI-Driven Enterprise business employs a combination of artificial intelligence and machine learning to enhance user experiences and simplify wireless and wired access operations.
AMN Healthcare has been making significant strides in patient engagement through technology. The use of digital technologies can ensure that patients with hearing difficulties receive proper care, a stellar example of how artificial intelligence is promoting inclusion and accessibility in healthcare systems.
The FDA has recently announced its commitment to the future of digital health. In 2024, the agency will launch a new Digital Health Advisory Committee that will oversee a broad spectrum of digital health technologies. The committee's mandate will be to navigate the complex scientific and technical issues related to these technologies, enhancing the FDA’s understanding of potential benefits, risks, and clinical outcomes.
Swedish fintech giant, Klarna, is introducing an AI-powered shopping lens. Similar to in-app lens tools provided by Google and Amazon, Klarna allows shoppers to take pictures of items or styles and then use its app to find where to buy the selected items. The company claims it can visually identify over 10 million items and match them with more than 50 million store offers. This tool uses AI to convert the image into a "shoppable item," thus streamlining the purchase process. Klarna is also getting creative with its consumer engagement - using shoppable videos powered by AI recommendation engines to drive consumer discovery and product promotion.
Links:
Samsung vows to up memory chip density to 'extreme levels'
Johnson & Johnson more interested in Korean bio startups
View Conference Explores AI’s Creative Potential, Presents ‘People Who Are Teaching Us How Not to Be Afraid of It’
What To Expect As Juniper Publishes Its Q3 Results?
Interpretation services are evolving with technology
Houston-based Tech Leader AMSYS Hires Industry Veteran John Rohrer as VP of Enterprise Sales
FDA to Create Digital Health Advisory Committee By 2024
Databricks Adds Unified Data Management Offering to AWS Marketplace; Aaron Kinworthy Quoted
Klarna AI Image Search Takes Aim at the E-Commerce Space
Comments